Key result
Transcatheter aortic valve replacement is an emerging technology that has made remarkable progress in the management of patients with severe aortic stenosis.
This review provides a brief introductory overview of the TAVR procedure, devices, trials, and registries for the management of severe aortic stenosis.
TAVR progress overview may guide clinician discussions; leaves open durability and expansion questions for randomized trials.
Transcatheter aortic valve replacement (TAVR) is an emerging technology for the management of patients with severe aortic stenosis (AS). First reported in 2002, TAVR has made remarkable progress in the past decade with completion of major randomized clinical trials, multiple observational registries, and evolution of several new devices. This article is a brief introductory overview of the TAVR procedure, devices, trials and registries, and newer developments in the field.
No takes yet. Share an insight, caveat, or question.
Harjai et al. (2013) conducted a review in Severe aortic stenosis. Transcatheter aortic valve replacement (TAVR) was evaluated. Transcatheter aortic valve replacement is an emerging technology that has made remarkable progress in the management of patients with severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: